Media Advisory “LET’S TALK ABOUT NETs” Campaign Shines Spotlight on Rare Cancer Toronto, ON – October 27, 2016 – Between 12,000 to 15,000 Canadians are estimated to have a rare [...]

By |2018-05-07T18:28:12-04:00October 27th, 2016|Awareness, News|Comments Off on “LET’S TALK ABOUT NETs”

ESMO 2016 NET News

Clinical benefit demonstrated with everolimus and pasireotide LAR alone or in combination in the first randomised, prospective study entirely dedicated to advanced lung and thymic carcinoids. In patients with advanced [...]

By |2018-05-07T18:28:12-04:00October 13th, 2016|Clinical Trial, News, Treatment News|Comments Off on ESMO 2016 NET News
Go to Top